EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer

Katarzyna Kaczmarek, Jerzy Więckiewicz, Ivo Que, Adrianna Gałuszka-Bulaga, Alan Chan, Maciej Siedlar, Jarek Baran

Archivum Immunologiae et Therapiae Experimentalis · 2024

DOI: 10.2478/aite-2024-0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2024. Verfasst von Katarzyna Kaczmarek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Lactococcus lactis, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis of sensitive cancer cells, including colorectal cancer (CRC). Due to its short biological half-life after intravenous administration and related clinical ineffectiveness, novel formulations of TRAIL need to be developed. Here we propose Lactococcus lactis bacteria as a vehicle for local delivery of human soluble TRAIL (hsTRAIL) in CRC. The use of common probiotics targeting guts as carriers for TRAIL could ensure its sustained release at the tumor site and extend the duration of its activity. We have already engineered hsTRAIL-secreting L.lactis bacteria and showed their effectiveness in elimination of human CRC cells in vitro and in vivo in a mouse subcutaneous model. Here, L.lactis (hsTRAIL+) were administered by gastric gavage to SCID mice with orthotopically developed HCT116 tumor in cecum, in monotherapy or in combination with metformin (MetF), already shown to enhance the hsTRAIL anti-tumor activity in subcutaneous CRC model. Oral administration of L.lactis (hsTRAIL+) resulted in significant progression of HCT116 tumors and shortening of the colon crypts. Secretion of hsTRAIL in the colon was accompanied by infiltration of the primary tumor with M2-macrophages, while MetF promoted transient colonization of the gut by L.lactis . Our study indicates that L.lactis bacteria after oral administration enable delivery of biologically active hsTRAIL to colon, however its potential therapeutic effect in CRC treatment is abolished by its pro-tumorigenic signalling, leading to the recruitment of M2-macrophages and tumor growth promotion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactococcus lactisColorectal NeoplasmsMiceAnimalsHumansMice, SCIDLigandsApoptosis

Stichwörter der Autor:innen

Colorectal cancerLactococcus lactisMetforminOrthotopic mice model of CRCTRAIL

Substanzen

Ligands

Autor:innen und Institutionen

  • Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
  • Translational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
  • Currently: Department of Radiology and Nuclear Medicine, Department of Molecular Genetics, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
  • Percuros B.V., Zernikedreef 8, 2333 CL Leiden, The Netherlands.

Zitieren

APA

Kaczmarek, K., Więckiewicz, J., Que, I., Gałuszka-Bulaga, A., Chan, A., Siedlar, M., & Baran, J. (2024). Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2024-0002

Vancouver

Kaczmarek K, Więckiewicz J, Que I, Gałuszka-Bulaga A, Chan A, Siedlar M, et al. Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer. Archivum Immunologiae et Therapiae Experimentalis. 2024. doi:10.2478/aite-2024-0002

BibTeX
@article{Kaczmarek2024,
  author = {Kaczmarek, Katarzyna and Więckiewicz, Jerzy and Que, Ivo and Gałuszka-Bulaga, Adrianna and Chan, Alan and Siedlar, Maciej and Baran, Jarek},
  title = {Human Soluble TRAIL Secreted by Modified Lactococcus lactis Bacteria Promotes Tumor Growth in the Orthotopic Mouse Model of Colorectal Cancer},
  journal = {Archivum Immunologiae et Therapiae Experimentalis},
  year = {2024},
  doi = {10.2478/aite-2024-0002}
}
Kostenlos starten →